
Raymond James Financial (RJF) has demonstrated robust performance, with LTM revenue up 11.8% to $13.77 billion and projected AUM growth to $1.885 trillion by 2027, supported by a 93.13% gross margin and record $1.6 trillion in client assets. While its strong capital position, including over $2 billion in excess capital, and consistent share repurchases underscore financial health, RJF faces challenges from decelerating organic growth in net new assets and market volatility impacting its capital markets business. Nevertheless, potential market normalization could reaccelerate revenue growth to 7-11% and drive 20% normalized EPS, with its significant excess capital offering flexibility for strategic investments and continued shareholder returns.
Raymond James Financial (RJF) presents a profile of robust financial health juxtaposed with specific growth and market-related headwinds. The company has delivered impressive performance, with last-twelve-months revenue growing 11.8% to $13.77 billion, an exceptional gross profit margin of 93.13%, and a stock price appreciation of over 43% in the past year, trading near its 52-week high. Its balance sheet is a key strength, featuring a Tier 1 leverage ratio of 13.3% and over $2 billion in excess capital, which management is actively deploying through share repurchases ($451 million in a recent quarter). Projections remain strong, with Assets Under Management (AUM) forecast to grow from $1.2 trillion in 2023 to $1.885 trillion by 2027. However, these strengths are tempered by a notable deceleration in organic growth, with net new assets slowing from a 7-9% rate in FY22-23 to a projected 4.0% in FY25. Furthermore, the capital markets division remains sensitive to market volatility, although strong investment banking pipelines suggest significant pent-up potential. A normalization of market conditions is a key catalyst, which analysts project could reaccelerate revenue growth to a 7-11% range and drive 20% normalized EPS growth.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
moderately positive
Sentiment Score
0.40
Ticker Sentiment